330 related articles for article (PubMed ID: 28784283)
1. Herpes zoster prevention: A difficult problem to solve.
Esposito S; Principi N
Vaccine; 2018 Aug; 36(36):5442-5448. PubMed ID: 28784283
[TBL] [Abstract][Full Text] [Related]
2. Vaccines for preventing herpes zoster in older adults.
Gagliardi AM; Andriolo BN; Torloni MR; Soares BG
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD008858. PubMed ID: 26937872
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine.
Grupping K; Campora L; Douha M; Heineman TC; Klein NP; Lal H; Peterson J; Vastiau I; Oostvogels L
J Infect Dis; 2017 Dec; 216(11):1343-1351. PubMed ID: 29029122
[TBL] [Abstract][Full Text] [Related]
4. Live attenuated herpes zoster vaccine for HIV-infected adults.
Shafran SD
HIV Med; 2016 Apr; 17(4):305-10. PubMed ID: 26315285
[TBL] [Abstract][Full Text] [Related]
5. The herpes zoster subunit vaccine.
Cunningham AL
Expert Opin Biol Ther; 2016; 16(2):265-71. PubMed ID: 26865048
[TBL] [Abstract][Full Text] [Related]
6. Vaccines for preventing herpes zoster in older adults.
Gagliardi AM; Gomes Silva BN; Torloni MR; Soares BG
Cochrane Database Syst Rev; 2012 Oct; 10():CD008858. PubMed ID: 23076951
[TBL] [Abstract][Full Text] [Related]
7. Herpes Zoster and Its Prevention by Vaccination.
Johnson RW; Levin MJ
Interdiscip Top Gerontol Geriatr; 2020; 43():131-145. PubMed ID: 32305975
[TBL] [Abstract][Full Text] [Related]
8. Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention.
Lecrenier N; Beukelaers P; Colindres R; Curran D; De Kesel C; De Saegher JP; Didierlaurent AM; Ledent EY; Mols JF; Mrkvan T; Normand-Bayle M; Oostvogels L; Da Silva FT; Vassilev V; Vinals C; Brecx A
Expert Rev Vaccines; 2018 Jul; 17(7):619-634. PubMed ID: 30028651
[TBL] [Abstract][Full Text] [Related]
9. Herpes Zoster Vaccines.
Harbecke R; Cohen JI; Oxman MN
J Infect Dis; 2021 Sep; 224(12 Suppl 2):S429-S442. PubMed ID: 34590136
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of vaccination of immunocompetent older adults against herpes zoster in the Netherlands: a comparison between the adjuvanted subunit and live-attenuated vaccines.
de Boer PT; van Lier A; de Melker H; van Wijck AJM; Wilschut JC; van Hoek AJ; Postma MJ
BMC Med; 2018 Dec; 16(1):228. PubMed ID: 30518427
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity, reactogenicity and safety of 2 doses of an adjuvanted herpes zoster subunit vaccine administered 2, 6 or 12 months apart in older adults: Results of a phase III, randomized, open-label, multicenter study.
Lal H; Poder A; Campora L; Geeraerts B; Oostvogels L; Vanden Abeele C; Heineman TC
Vaccine; 2018 Jan; 36(1):148-154. PubMed ID: 29174683
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of an Adjuvanted Recombinant Zoster Vaccine in older adults in the United States.
Curran D; Patterson B; Varghese L; Van Oorschot D; Buck P; Carrico J; Hicks K; Lee B; Yawn B
Vaccine; 2018 Aug; 36(33):5037-5045. PubMed ID: 30017145
[TBL] [Abstract][Full Text] [Related]
13. Shingrix: The New Adjuvanted Recombinant Herpes Zoster Vaccine.
James SF; Chahine EB; Sucher AJ; Hanna C
Ann Pharmacother; 2018 Jul; 52(7):673-680. PubMed ID: 29457489
[TBL] [Abstract][Full Text] [Related]
14. Zoster vaccine live.
Kockler DR; McCarthy MW
Pharmacotherapy; 2007 Jul; 27(7):1013-9. PubMed ID: 17594207
[TBL] [Abstract][Full Text] [Related]
15. [Vaccines against varicella-zoster virus (VZV)].
Salleras L; Salleras M; Soldevila N; Prat A; Garrido P; Domínguez Á
Enferm Infecc Microbiol Clin; 2015; 33(6):411-23. PubMed ID: 26096575
[TBL] [Abstract][Full Text] [Related]
16. Shingles (Herpes Zoster) Vaccine (Zostavax(®)): A Review in the Prevention of Herpes Zoster and Postherpetic Neuralgia.
Keating GM
BioDrugs; 2016 Jun; 30(3):243-54. PubMed ID: 27189459
[TBL] [Abstract][Full Text] [Related]
17. Herpes Zoster Vaccination: Controversies and Common Clinical Questions.
Van Epps P; Schmader KE; Canaday DH
Gerontology; 2016; 62(2):150-4. PubMed ID: 26184711
[TBL] [Abstract][Full Text] [Related]
18. Safety and immunogenicity of an AS01-adjuvanted varicella zoster virus subunit candidate vaccine (HZ/su): a phase-I, open-label study in Japanese adults.
Lal H; Zahaf T; Heineman TC
Hum Vaccin Immunother; 2013 Jul; 9(7):1425-9. PubMed ID: 23584252
[TBL] [Abstract][Full Text] [Related]
19. Vaccination: a new option to reduce the burden of herpes zoster.
Mick G
Expert Rev Vaccines; 2010 Mar; 9(3 Suppl):31-5. PubMed ID: 20192716
[TBL] [Abstract][Full Text] [Related]
20. The comparative efficacy and safety of herpes zoster vaccines: A network meta-analysis.
McGirr A; Widenmaier R; Curran D; Espié E; Mrkvan T; Oostvogels L; Simone B; McElhaney JE; Burnett H; Haeussler K; Thano A; Wang X; Newson RS
Vaccine; 2019 May; 37(22):2896-2909. PubMed ID: 30982636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
